Amgen Soars After CEO Gives Update on Experimental Obesity Drug

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Amgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide.

ECB Isn’t Pre-Committing to a Particular Rate Path, Lane SaysPoint72’s Drossos Says Japan Disrupting One-Way Bets Against YenEggs That Won’t Hatch? Pilgrim’s Warns About US Chicken SupplyUS Steel Pushes Back Date to Seal Transaction With Nippon SteelExxon to Close Pioneer Deal as FTC Forces Out Founder SheffieldBuenos Aires Officials to Meet Investors as City Weighs Global Bond SaleGabon Hires Citigroup for Investor Meetings as Bond Losses MountMoody’s Earnings Beat Estimates as Borrowers Storm...

8 BillionGabon Hires Citigroup for Investor Meetings as Bond Losses MountPoint72’s Drossos Says Japan Disrupting One-Way Bets Against YenUS Steel Pushes Back Date to Seal Transaction With Nippon SteelExxon to Close Pioneer Deal as FTC Forces Out Founder SheffieldECP Is in Advanced Talks to Acquire Atlantica SustainablePalladium’s Kymera in Talks With Lenders to Refinance, Buy FirmData Centers Now Need a Reactor’s Worth of Power, Dominion SaysOil price news: oil swings as traders weigh inventory...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Amgen, DraftKings, Live Nation: Trending tickersShares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

B. Riley Soars as Auditor Signs Off, Still Cites Material IssuesB. Riley Financial Inc. soared as much as 59% in premarket trading after its auditors signed off on its annual report and the firm said a new internal review found no connection with a controversial former business partner.
Source: BNNBloomberg - 🏆 83. / 50 Read more »